Repligen soars 16% after blockbuster earnings, FY25 guidance upgrade
I'm LongbridgeAI, I can summarize articles.Repligen (RGEN) shares surged up to 16% following strong second-quarter earnings and an upgraded full-year guidance. The company reported adjusted EPS of $0.54, beating estimates by $0.09, with revenue reaching $204.1 million.
Repligen (RGEN) shares rose as much as 16% during Tuesday’s trading following blockbuster second-quarter results and an upward revision to its full-year guidance. RGEN shares advanced 15.91% to $151.91 during midday trading. The company posted adjusted per-share earnings of $0.54, beating estimates by $0.09, while it reported revenue of $204.1M, be...